prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, PROCEDURE. Right breast lumpectomy. SPECIMEN: A. R. breast lump. Nylon suture at posterior margin. Beige suture. superior margin. B. Sentinel node #1. C. Sentinel node #2. D. Right breast tissue (black suture most superior margin) . E. Right breast tissue (black suture at most anterior margin). HISTORY. Right breast cancer. GROSS. A. Received fresh in a container labeled "right breast tissue" is. a. fragment of fibrofatty breast tissue (5.7 cm in medial-lateral. dimension, 7 cm in superior-inferior dimension, 1.8 cm in. anterior-posterior dimension) oriented by attached sutures. An. accompanying specimen radiograph reveals abundant radiodense. tissue. The density corresponds to a sclerotic, gray-white, hard tumor mass. (2.8 cm in greatest dimension) which is within 1-2 mm of the. anterior margin, 0.5 cm from the posterior margin, 0.6 cm from the. medial margin, approximately 1.4 cm from the lateral margin and 1.2. cm from the superior margin. The remaining parenchyma consists of. abundant firm white fibrous tissue with scattered cysts up to 2-3 mm. in diameter, along with dilated ducts containing opaque yellow-tan,. paste-like material. Total fixation time in formalin is. approximately 28 hours. A representative portion of the tumor is. submitted for the. Ink Code: Black - posterior. Blue - anterior. Green - lateral. Red - medial. Orange - superior. Purple - inferior. 1. Superior margin. 2-3 and 4-5. Full thickness bisected cross sections, including. nearest radial margins. 6-7. Indurated parenchyma away from tumor. 8. Inferior margin. B. Received in formalin in a container labeled "sentinel node. #1". is. a 1.8 cm in greatest dimension, blue-gray, fatty lymph node. C. Received in formalin in a container labeled sentinel node #2". is a 0.6 cm, firm, tan and gray lymph node. D. Received in formalin in a container labeled "right breast. tissue, black suture most superior margin" is a sheet of fibrofatty. tissue (4 x 3 x 1.2 cm) oriented by an attached suture. Ink Code: Black - superior margin (adjacent to suture). Blue - opposing margin. The tissue is serially sectioned and submitted in its entirety in. three cassettes. E. Received in formalin in a container labeled right breast tissue. black suture most anterior margin" is a fragment of fibrofatty. tissue (2.9 x 1.6 x 0.9 cm) oriented by an attached suture. Ink Code: Black - anterior margin (adjacent to suture) . Blue - opposing margin. The specimen is serially sectioned and submitted in its entirety in. two cassettes. MICROSCOPIC. See diagnosis. DIAGNOSIS. A. Right breast lump, lumpectomy: Invasive lobular carcinoma (see comment) . B. Sentinel lymph node #1, excision: One lymph node involved by metastatic adenocarcinoma (largest. metastatic focus 2 mm) (1/1) . C. Sentinel lymph node #2, excision: One benign lymph node, free of tumor (0/1) . D. Right breast tissue, excision: Microscopic foci of invasive lobular carcinoma (up to 5 mm in. greatest dimension). Tiny focus of lobular cancerization. Neoplasm is approximately 4-5 mm from most superior margin. (black inked margin, adjacent to suture) and at blue inked. opposing aspect. E. Right breast tissue, excision: No tumor is seen. COMMENT. BREAST CARCINOMA SUMMARY: SPECIMEN: Partial breast. PROCEDURE: Lumpectomy. SPECIMEN INTEGRITY: Single intact with additional margin submitted. in parts C (superior margin) and D (anterior margin). SPECIMEN LATERALITY: Right breast lumpectomy. SPECIMEN SIZE: 5.7 x 7 x 1.8 cm. TUMOR SIZE: 2.8 cm. TUMOR FOCALITY: A 2.8 cm focus of invasive lobular carcinoma, and. additional tiny foci (up to 5 mm) of invasive lobular carcinoma away. from tumor. SKIN INVOLVEMENT: Skin not present. NIPPLE INVOLVEMENT: Nipple not present. SKELETAL MUSCLE INVOLVEMENT: Skeletal muscle not present. DUCTAL CARCINOMA IN SITU (DCIS) : Negative. LOBULAR CARCINOMA IN SITU (LCIS) : Present. HISTOLOGIC TYPE: Invasive lobular carcinoma. GRADING (NOTTINGHAM) : Tubular formation score: Score 3. NUCLEAR PLEOMORPHISM SCORE: Score 2. MITOTIC RATE SCORE: Score 1. COMBINED GRADE (NOTTINGHAM) : Grade 2 (intermediate grade) . LYMPHOVASCULAR INVASION: Not identified. MARGIN OF EXCISION: Final margins appear free of tumor (closest. margin is superior, approximately 4-5 mm. part D). LYMPH NODES: One sentinel lymph node involved by metastatic lobular. carcinoma (sentinel lymph node #1, part B (largest tumor focus is 2. mm) (1/2). MICROCALCIFICATION: Not identified. OTHER FINDINGS: Fibrocystic changes, usual ductal hyperplasia. HORMONE RECEPTORS: Reported (estrogen receptor positive (70%,. strong) i Progesterone receptor positive (over 90%, strong). HER-2/NEU: Reported (equivocal (2+) by immunohistochemistry,. FISH pending. PATHOLOGIC TNM (AJCC EDITION) : T2 N1mic MX. NOTE: A cytokeratin E1/E3 immunohistochemical stain was performed. on parts B (sentinel lymph node #1) and C (sentinel lymph node #2). It is strongly positive on part B (sentinel lymph node #1) within. the metastatic tumor cells, and supports the diagnosis. It is. negative within part c (sentinel lymph node #2), consistent with. benign lymph node. ?ctronic Signature). Completed Action List: on. Type: Sura Path Final Report. Title:

expanded version (tokens=1819) : 
 Histological classification: Invasive lobular carcinoma.

Subtype: LumA.

Description of necrosis: Not mentioned.

Tumor infiltrating lymphocytes: Not identified.

Histological grade: Grading (Nottingham) score: Tubular formation score-3, Nuclear pleomorphism score-2, Mitotic rate score-1, Combined Grade (Nottingham)-Grade 2 (intermediate grade).

Nuclear grade: Score 2.

Lymphovascular invasion: Not identified.

Calcification: Microcalcification not identified.

Receptor status: Estrogen receptor positive (70%, strong), progesterone receptor positive (over 90%, strong), Her-2/Neu equivocal with Immunohistochemistry, FISH pending.

Ancillary testing results: CK E1/E3 immunohistochemistry stain was performed on sentinel lymph nodes #1 and #2, which revealed a strongly positive metastatic tumor in the sentinel lymph node #1 but the node in sentinel lymph node #2 is negative.

Additional findings: The report also identified the presence of lobular carcinoma in situ. Fibrocystic changes and usual ductal hyperplasia were seen. No skin, nipple or skeletal muscle involvement was observed.

Margins: Final margins appear free of tumor (closest margin is superior, approximately 4-5 mm. part D).

TNM staging: T2 N1mic MX.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2014) : 
 Report: Histopathology of the lumpectomy biopsy shows invasive lobular carcinoma, subtype LumA. Microscopic foci of invasive lobular carcinoma (up to 5mm) were found in the excised right breast tissue and no tumors were seen in the right breast tissue fragment received from a different site. The grading score is 2 with no lymphovascular invasion but 1 out of 2 sentinel lymph nodes #1 involved by metastatic adenocarcinoma. Hormonal receptors are positive for both estrogen and progesterone but Her-2/Neu is equivocal with immunohistochemistry (FISH pending). Final margin appears free of tumor. TNM staging: T2 N1mic MX.


